Literature DB >> 11716127

Case report: Retinopathy after malaria prophylaxis with chloroquine.

S Bertagnolio1, E Tacconelli, G Camilli, M Tumbarello.   

Abstract

Chloroquine retinopathy (CR) is a major complication of long-term malaria prophylaxis (LTMP) causing permanent visual dysfunction and occasionally blindness. After an extensive review of the published accounts of CR, we concluded that the risk of retinopathy in subjects receiving LTMP is limited to a cumulative dose that does not exceed 140 g. We present a case of CR that occurred after 8 years of malaria prophylaxis with chloroquine at a cumulative dose of 125 g. Because a threshold dose of chloroquine for retinal toxicity has not been established, careful, ongoing screening is required, especially as the cumulative dose increases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716127     DOI: 10.4269/ajtmh.2001.65.637

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

Review 1.  Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.

Authors:  S Balachandar; A Katyal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-09       Impact factor: 3.267

Review 2.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Delayed onset chloroquine retinopathy presenting 10 years after long-term usage of chloroquine.

Authors:  Mohmmad Salman Kazi; Kumar Saurabh; Pukhraj Rishi; Ekta Rishi
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.